Cme Group Stock Today

CME Stock  USD 306.76  0.48  0.16%   

Performance

Good

 
Weak
 
Strong

Odds Of Distress

Tiny

 
High
 
Low
CME is trading at 306.76 as of the 10th of February 2026, a 0.16 percent decrease since the beginning of the trading day. The stock's lowest day price was 302.55. CME has a very small chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Note, on January 16, 2026, Representative Julie Johnson of US Congress acquired under $15k worth of CME Group's common stock.
Business Domain
Financial Services
IPO Date
6th of December 2002
Classification
Financials
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois. CME operates under Financial Data Stock Exchanges classification in the United States and is traded on NASDAQ Exchange. The company has 359.51 M outstanding shares of which 4.21 M shares are currently shorted by investors with about 2.28 days to cover. More on CME Group

Moving together with CME Stock

  0.66MLNMA Nicolas Miguet etPairCorr

Moving against CME Stock

  0.81MORN Morningstar Earnings Call This WeekPairCorr
  0.77FDS FactSet Research SystemsPairCorr
  0.65X TMX Group LimitedPairCorr
  0.55ATHR Aether HoldingsPairCorr
  0.5ENX Euronext NV Earnings Call Next WeekPairCorr
  0.5AGMH AGM Group HoldingsPairCorr

CME Stock Highlights

ESG Sustainability
Environmental
Governance
Social
ChairmanTerrence Duffy
Thematic IdeaBlockchain (View all Themes)
Old Names[Central European Media Enterprises Ltd, CENTRAL EURO MEDI-A (CME.SG), AM METALS UCITS ETF, AM METALS UCITS ETF]
Business ConcentrationFinancial Exchanges & Data, Financial Data & Stock Exchanges, Financial Services, SP 500 Index, NASDAQ Composite, NASDAQ Financial 100, NASDAQ Composite Total, Nasdaq Real Estate, Blockchain, Financials, Capital Markets, Financial Data & Stock Exchanges, Financial Services (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.03120.0329
Notably Down
Slightly volatile
Gross Profit Margin0.660.8609
Way Down
Slightly volatile
Total Current Liabilities168.3 B160.3 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total7.4 B9.9 B
Way Down
Slightly volatile
Total Assets208.3 B198.4 B
Sufficiently Up
Slightly volatile
Total Current Assets124.4 B118.5 B
Sufficiently Up
Slightly volatile
Total Cash From Operating Activities4.5 B4.2 B
Sufficiently Up
Slightly volatile
Debt Levels
By employing borrowed capital, CME can potentially magnify investment returns. Examining the debt-to-assets ratio offers investors perspective on CME's use of financial leverage and reveals what portion of CME's asset base relies on creditor financing.
Liquidity
CME Group has 3.42 B in debt with debt to equity (D/E) ratio of 0.12, which may show that the company is not taking advantage of profits from borrowing. CME Group has a current ratio of 1.0, demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. That said, strategic use of leverage may enable CME to fund expansion initiatives and generate superior returns.

Free Cash Flow

4.34 Billion
CME Group (CME) is traded on NASDAQ Exchange in USA and employs 3,760 people. CME is listed under Financial Exchanges & Data category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a total capitalization of 110.46 B. CME Group runs under Capital Markets sector within Financials industry. The entity has 359.51 M outstanding shares of which 4.21 M shares are currently shorted by investors with about 2.28 days to cover. CME Group has about 2.22 B in cash with 3.69 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.19.
Check CME Probability Of Bankruptcy
Ownership Allocation
CME holds a total of 359.51 Million outstanding shares. The majority of CME Group outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in CME Group to benefit from reduced commissions. Thereupon, institutional investors are subject to a different set of regulations than regular investors in CME. Please pay attention to any change in the institutional holdings of CME Group as this could imply that something significant has changed or is about to change at the company. Please note that on January 16, 2026, Representative Julie Johnson of US Congress acquired under $15k worth of CME Group's common stock.
Check CME Ownership Details

CME Stock Institutional Holders

InstituionRecorded OnShares
Capital Research & Mgmt Co - Division 32025-06-30
4.5 M
Fmr Inc2025-06-30
M
Arrowstreet Capital Limited Partnership2025-06-30
3.8 M
Northern Trust Corp2025-06-30
3.8 M
Gqg Partners Llc2025-06-30
3.6 M
Royal Bank Of Canada2025-06-30
3.4 M
Franklin Resources Inc2025-06-30
3.4 M
Fidelity International Ltd2025-06-30
3.2 M
Ubs Asset Mgmt Americas Inc2025-06-30
3.1 M
Vanguard Group Inc2025-06-30
35.2 M
Blackrock Inc2025-06-30
30 M
View CME Diagnostics

CME Historical Income Statement

At present, CME's Gross Profit is projected to increase significantly based on the last few years of reporting. The current year's Operating Income is expected to grow to about 4.4 B, whereas Selling And Marketing Expenses is forecasted to decline to 1.09. View More Fundamentals

CME Stock Against Markets

CME Corporate Directors

Hilda PiellChief Human Resource Officer, Senior Managing DirectorProfile
Jack TobinChief Accounting Officer, Managing DirectorProfile
Derek SammannSenior Managing Director - Financial Products and ServicesProfile
Julie WinklerSenior Managing Director - Research and Product DevelopmentProfile
When determining whether CME Group is a strong investment it is important to analyze CME's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CME's future performance. For an informed investment choice regarding CME Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Will Financial Exchanges & Data sector continue expanding? Could CME diversify its offerings? Factors like these will boost the valuation of CME. Projected growth potential of CME fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every CME data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.35
Dividend Share
5
Earnings Share
11.34
Revenue Per Share
18.131
Quarterly Revenue Growth
0.083
CME Group's market price often diverges from its book value, the accounting figure shown on CME's balance sheet. Smart investors calculate CME's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since CME's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between CME's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CME should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.